OmniaBio: Bringing Maturity to Cell and Gene Therapy (Drone Video)

At 120,000 square feet, and visible from the highway that passes alongside McMaster Innovation Park in Hamilton, Ontario, OmniaBio Inc. is a beacon for cell and gene therapy companies.

A subsidiary of CCRM, OmniaBio is built on a strong foundation established more than a decade ago. With the singular purpose of optimizing and manufacturing cells and viral vectors, OmniaBio is bringing maturity to the industry: it will be Canada’s largest contract manufacturer dedicated to cell and gene therapies.

Learn more about OmniaBio at

All other pages contact

For more information, please contact us.

Subscribe to our mailing list to receive CCRM’s monthly newsletter.


You have Successfully Subscribed!